NatureCell Co.Ltd
NatureCell Co.,Ltd. manufactures and sells canned and health functional food products, beverages, stem cell, and cosmetics in South Korea and internationally. The company's products comprise fruit drinks, aloe vera drinks, coffee, energy drinks, and Korean sauces, as well as offers domestic products and ETC products under the SAMMI and OEM brands. It also provides services for the preservation of… Read more
Market Cap & Net Worth: NatureCell Co.Ltd (007390)
NatureCell Co.Ltd (KQ:007390) has a market capitalization of $657.93 Million (₩963.34 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22536 globally and #1154 in its home market, demonstrating a -5.47% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NatureCell Co.Ltd's stock price ₩18150.00 by its total outstanding shares 53076400 (53.08 Million).
NatureCell Co.Ltd Market Cap History: 2015 to 2026
NatureCell Co.Ltd's market capitalization history from 2015 to 2026. Data shows growth from $163.28 Million to $657.93 Million (16.04% CAGR).
Index Memberships
NatureCell Co.Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.02% | #557 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.02% | #557 of 1384 |
Weight: NatureCell Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
NatureCell Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NatureCell Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
NatureCell Co.Ltd's market cap is 0.02 times its annual revenue
0.01x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
0.64x
NatureCell Co.Ltd's market cap is 0.64 times its annual earnings
0.18x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $163.28 Million | $30.55 Billion | -$1.34 Billion | 0.01x | N/A |
| 2016 | $157.69 Million | $26.79 Billion | -$3.22 Billion | 0.01x | N/A |
| 2017 | $780.83 Million | $27.22 Billion | -$460.74 Million | 0.03x | N/A |
| 2018 | $403.12 Million | $26.72 Billion | $2.23 Billion | 0.02x | 0.18x |
| 2019 | $238.88 Million | $23.07 Billion | $902.01 Million | 0.01x | 0.26x |
| 2020 | $371.56 Million | $16.72 Billion | -$18.87 Billion | 0.02x | N/A |
| 2021 | $645.24 Million | $22.20 Billion | -$32.03 Billion | 0.03x | N/A |
| 2022 | $552.80 Million | $21.25 Billion | -$6.81 Billion | 0.03x | N/A |
| 2023 | $289.63 Million | $19.35 Billion | -$11.68 Billion | 0.01x | N/A |
| 2024 | $779.36 Million | $32.33 Billion | $1.23 Billion | 0.02x | 0.64x |
Competitor Companies of 007390 by Market Capitalization
Companies near NatureCell Co.Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to NatureCell Co.Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3465 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #6393 globally with a market cap of $1.27 Billion USD ( ₩1.86 Trillion KRW).
- Kolon Life Science Inc (KQ:102940): Ranked #12728 globally with a market cap of $306.22 Million USD ( ₩448.36 Billion KRW).
- DongKook Pharmaceutical Co. Ltd (KQ:086450): Ranked #12931 globally with a market cap of $294.94 Million USD ( ₩431.85 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3465 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩739000.00 |
| #6393 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.27 Billion | ₩89200.00 |
| #12728 | Kolon Life Science Inc | KQ:102940 | $306.22 Million | ₩61000.00 |
| #12931 | DongKook Pharmaceutical Co. Ltd | KQ:086450 | $294.94 Million | ₩18140.00 |
NatureCell Co.Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, NatureCell Co.Ltd's market cap moved from $163.28 Million to $ 657.93 Million, with a yearly change of 16.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩657.93 Million | -16.74% |
| 2025 | ₩790.24 Million | +1.40% |
| 2024 | ₩779.36 Million | +169.09% |
| 2023 | ₩289.63 Million | -47.61% |
| 2022 | ₩552.80 Million | -14.33% |
| 2021 | ₩645.24 Million | +73.66% |
| 2020 | ₩371.56 Million | +55.54% |
| 2019 | ₩238.88 Million | -40.74% |
| 2018 | ₩403.12 Million | -48.37% |
| 2017 | ₩780.83 Million | +395.17% |
| 2016 | ₩157.69 Million | -3.42% |
| 2015 | ₩163.28 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NatureCell Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $657.93 Million USD |
| MoneyControl | $657.93 Million USD |
| MarketWatch | $657.93 Million USD |
| marketcap.company | $657.93 Million USD |
| Reuters | $657.93 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.